ASCLS eNewsBytes

• Blood-brain barrier changes may explain Parkinson's disease progression November 22, 2021
  A study in the journal Neurology Genetics suggests that experts could use the expression of certain microRNAs in the cerebrospinal fluid of people with Parkinson's disease not only to follow disease progression but also to determine if a new Parkinson's disease drug works.
• 30 seconds to cure cervical cancer: New technology opens door to rapid treatment November 22, 2021
  Treating cervical cancer in future may take just 30 seconds thanks to a futuristic-looking device. The technology, recently recommended by WHO, was introduced in Uzbekistan at a WHO training course preparing the country’s health professionals to use the new equipment in outpatient clinics.
• Patient risk, not disease duration, key to timing biologics in IBD November 22, 2021
  The decision to initiate biologics early in the treatment of Crohn's disease and ulcerative colitis should be based on complication risk, not on the assumption that earlier treatment produces better results, new research suggests.
• COVID-19 booster shot increases protection in cancer patients November 22, 2021
  COVID-19 booster shots generated immune responses in cancer patients who had no detectable antibodies after primary vaccination, researchers said. Among seronegative patients, a third dose of vaccine achieved a 56% seroconversion rate, reported Balazs Halmos, MD, MS, of Montefiore Einstein Cancer Center in New York City, and colleagues.
• Disease-modifying drug use in pregnancy tied to less postpartum relapses in MS November 22, 2021
  Women with relapsing multiple sclerosis who have exposure to disease-modifying drugs in early pregnancy have fewer postpartum relapses, according to study results presented at the 2021 Consortium of Multiple Sclerosis Centers Annual Meeting.